BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 12837515)

  • 21. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients.
    Kale A; Joshi S; Naphade N; Sapkale S; Raju MS; Pillai A; Nasrallah H; Mahadik SP
    Schizophr Res; 2008 Jan; 98(1-3):295-301. PubMed ID: 17997280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antioxidant supplementation for lung disease in cystic fibrosis.
    Ciofu O; Lykkesfeldt J
    Cochrane Database Syst Rev; 2014 Aug; (8):CD007020. PubMed ID: 25102015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of omega-3 fatty acid plus alpha-tocopherol supplementation on malnutrition-inflammation score, biomarkers of inflammation and oxidative stress in chronic hemodialysis patients.
    Asemi Z; Soleimani A; Shakeri H; Mazroii N; Esmaillzadeh A
    Int Urol Nephrol; 2016 Nov; 48(11):1887-1895. PubMed ID: 27554670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The impact of non-surgical periodontal treatment on serum levels of long chain-polyunsaturated fatty acids: a pilot randomized clinical trial.
    Martinez GL; Koury JC; Brito F; Fischer RG; Gustafsson A; Figueredo CM
    J Periodontal Res; 2014 Apr; 49(2):268-74. PubMed ID: 23721647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omega-3 fatty acids reduce cardiometabolic risk in first-episode schizophrenia patients treated with antipsychotics: Findings from the OFFER randomized controlled study.
    Pawełczyk T; Grancow-Grabka M; Żurner N; Pawełczyk A
    Schizophr Res; 2021 Apr; 230():61-68. PubMed ID: 33684737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease.
    Kontush A; Mann U; Arlt S; Ujeyl A; Lührs C; Müller-Thomsen T; Beisiegel U
    Free Radic Biol Med; 2001 Aug; 31(3):345-54. PubMed ID: 11461772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder.
    Hibbeln JR; Makino KK; Martin CE; Dickerson F; Boronow J; Fenton WS
    Biol Psychiatry; 2003 Mar; 53(5):431-41. PubMed ID: 12614996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Omega-3 and Omega-6 Polyunsaturated Fatty Acid Levels and Correlations with Symptoms in Children with Attention Deficit Hyperactivity Disorder, Autistic Spectrum Disorder and Typically Developing Controls.
    Parletta N; Niyonsenga T; Duff J
    PLoS One; 2016; 11(5):e0156432. PubMed ID: 27232999
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Omega-3 fatty acids for postoperative atrial fibrillation: alone or in combination with antioxidant vitamins?
    Guo XY; Yan XL; Chen YW; Tang RB; Du X; Dong JZ; Ma CS
    Heart Lung Circ; 2014 Aug; 23(8):743-50. PubMed ID: 24685324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporation and clearance of omega-3 fatty acids in erythrocyte membranes and plasma phospholipids.
    Cao J; Schwichtenberg KA; Hanson NQ; Tsai MY
    Clin Chem; 2006 Dec; 52(12):2265-72. PubMed ID: 17053155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized controlled trial to prevent post-operative atrial fibrillation by antioxidant reinforcement.
    Rodrigo R; Korantzopoulos P; Cereceda M; Asenjo R; Zamorano J; Villalabeitia E; Baeza C; Aguayo R; Castillo R; Carrasco R; Gormaz JG
    J Am Coll Cardiol; 2013 Oct; 62(16):1457-65. PubMed ID: 23916928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased ω-3 polyunsaturated fatty acid/arachidonic acid ratios and upregulation of signaling mediator in individuals with autism spectrum disorders.
    Yui K; Imataka G; Kawasak Y; Yamada H
    Life Sci; 2016 Jan; 145():205-12. PubMed ID: 26724495
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of long-term fish oil supplementation on vitamin E status and lipid peroxidation in women.
    Meydani M; Natiello F; Goldin B; Free N; Woods M; Schaefer E; Blumberg JB; Gorbach SL
    J Nutr; 1991 Apr; 121(4):484-91. PubMed ID: 1826131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia.
    Peet M; Brind J; Ramchand CN; Shah S; Vankar GK
    Schizophr Res; 2001 Apr; 49(3):243-51. PubMed ID: 11356585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eicosapentaenoic Acid Versus Docosahexaenoic Acid as Options for Vascular Risk Prevention: A Fish Story.
    Singh S; Arora RR; Singh M; Khosla S
    Am J Ther; 2016; 23(3):e905-10. PubMed ID: 25828517
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia.
    Mahadik SP; Pillai A; Joshi S; Foster A
    Int Rev Psychiatry; 2006 Apr; 18(2):119-31. PubMed ID: 16777666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of Ginkgo biloba extract added to haloperidol on peripheral T cell subsets in drug-free schizophrenia: a double-blind, placebo-controlled trial.
    Zhang XY; Zhou DF; Cao LY; Wu GY
    Psychopharmacology (Berl); 2006 Sep; 188(1):12-7. PubMed ID: 16906395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome.
    Rahmani E; Samimi M; Ebrahimi FA; Foroozanfard F; Ahmadi S; Rahimi M; Jamilian M; Aghadavod E; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z
    Mol Cell Endocrinol; 2017 Jan; 439():247-255. PubMed ID: 27619403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hostility of drug-free patients with schizophrenia and n-3 polyunsaturated fatty acid levels in red blood cells.
    Watari M; Hamazaki K; Hirata T; Hamazaki T; Okubo Y
    Psychiatry Res; 2010 May; 177(1-2):22-6. PubMed ID: 20227767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.
    Markworth JF; Kaur G; Miller EG; Larsen AE; Sinclair AJ; Maddipati KR; Cameron-Smith D
    FASEB J; 2016 Nov; 30(11):3714-3725. PubMed ID: 27461565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.